Plausibility of the combination of 17 α hydroxyprogesterone injection and Nifedipine versus Magnesium sulfate in the management of preterm labor, RCT
Keywords:
preterm labor, nifedipine, 17 α hydroxyprogesterone, Mgso4Abstract
Background: Preterm birth is the leading cause of neonatal mortality and the most common reason for neonatal admission to the hospital. Although the causes of preterm labor are not well understood, the burden of preterm births is clear—preterm births account for approximately 70% of neonatal deaths and 36% of infant deaths as well as 25–50% of cases of long-term neurologic impairment in children. Objective: To compare the effectiveness of the tocolytic action of the standard protocol of Magnesium sulfate versus the combination of Nifedipine and 17 α hydroxyprogesterone injection in the term of acute tocolysis therapy on the perinatal outcome and to abrupt threatened preterm labor between 24 weeks to 33 weeks and 6 days. Patients and methods: A prospective randomized control trial study conducted at Zagazig Maternity Hospital, included 102 pregnant women who presented with threatened preterm labor at the Emergency Department of Zagazig University Maternity Hospital. The participants were divided into two groups, group (1) included 51 cases who received the standard protocol of Magnesium Sulfate: loading dose 4 g IV; maintenance 2 g/hr for 24 hrs.
Downloads
References
Afsharpaiman S, Torkaman M, Saburi A, Farzaampur A, Amirsalari S, Kavehmanesh Z. Trends in the incidence of neonatal sepsis and antibiotic susceptibility of causative agents in two neonatal intensive care units in Tehran, IR Iran. Journal of clinical neonatology. 2012 Jul;1(3):124.
Bonanno C, Wapner RJ. Antenatal corticosteroids in the management of preterm birth: are we back where we started? Obstetrics and Gynecology Clinics. 2012 Mar 1;39(1):47-63.
Boyle AK, Rinaldi SF, Norman JE, Stock SJ. Preterm birth: Inflammation, fetal injury and treatment strategies. Journal of reproductive immunology. 2017 Feb 1;119:62-6.
Dodd JM, Jones L, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane Database of Systematic Reviews. 2013(7).
Escobar GJ, McCormick MC, Zupancic JA, Coleman-Phox K, Armstrong MA, Greene JD, Eichenwald EC, Richardson DK. Unstudied infants: outcomes of moderately premature infants in the neonatal intensive care unit. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2006 Jul 1;91(4):F238-44.
Flenady V, Wojcieszek AM, Papatsonis DN, Stock OM, Murray L, Jardine LA, Carbonne B. Calcium channel blockers for inhibiting preterm labor and birth. Cochrane Database of Systematic Reviews. 2014(6).
Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. New England Journal of Medicine. 2007 Aug 2;357(5):462-9.
Food and Drug Administration. Clinical Review, 17-alpha hydroxyprogesterone caproate, NDA 21–945 2011.
Han S, Crowther CA, Moore V. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labor. Cochrane Database of Systematic Reviews. 2013(5).
Haram K, Mortensen JH, Morrison JC. Tocolysis for acute preterm labor: does anything work? The Journal of Maternal-Fetal & Neonatal Medicine. 2015 Mar 4;28(4):371-8.
Lee MJ, Guinn D, Martin R. Antenatal corticosteroid therapy for reduction of neonatal respiratory morbidity and mortality from preterm delivery. UpToDate. Waltham, MA: UpToDate. 2018.
Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, Spong CY, Hauth JC, Miodovnik M, Varner MW, Leveno KJ. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproates. New England Journal of Medicine. 2003 Jun 12;348(24):2379-85.
Multicentre Premature Labour Study Group, Takagi K, Satoh K. Is long-term tocolysis effective for threatened premature labor? Journal of International Medical Research. 2009 Feb;37(1):227-39.
Navathe R, Berghella V. Tocolysis for acute preterm labor: where have we been, where are we now, and where are we going? American journal of perinatology. 2016 Feb;33(03):229-35.
Nikbakht R, Taheri Moghadam M, Ghane'ee H. Nifedipine compared to magnesium sulfate for treating preterm labor: A randomized clinical trial. Iran J Reprod Med. 2014;12(2):145-50.
O’Brien JM, Lewis DF. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety. American Journal of Obstetrics and Gynecology. 2016 Jan 1;214(1):45-56.
Padovani TR, Guyatt G, Lopes LC. Nifedipine versus terbutaline, tocolytic effectiveness, and maternal and neonatal adverse effects: a randomized, controlled pilot trial. Basic & Clinical Pharmacology & Toxicology. 2015 Mar;116(3):244-50.
Piette PC. The pharmacodynamics and safety of progesterone. Best Practice & Research Clinical Obstetrics & Gynaecology. 2020 Nov 1;69:13-29.
Prior M, Thornton J. Progesterone has no place in the prevention of preterm delivery: FOR: It is time to study something else. BJOG: An International Journal of Obstetrics & Gynaecology. 2016 Aug 1;123(9).
Romero, R., Nicolaides, K.H., Conde‐Agudelo, A., O'Brien, J.M., Cetingoz, E., Da Fonseca, E., Creasy, G.W. and Hassan, S.S., 2016. Vaginal progesterone decreases preterm birth≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta‐analysis including data from the OPTIMUM study. Ultrasound in Obstetrics & Gynecology, 48(3), pp.308-317.
Surbek D, Drack G, Irion O, Nelle M, Huang D, Hoesli I. Antenatal corticosteroids for fetal lung maturation in threatened preterm delivery: indications and administration. Archives of gynecology and obstetrics. 2012 Aug;286(2):277-81.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
